mhurhangee/patent-ind-claim-en huggingface dataset:
Use of a combination of metabolites contained in a blood sample of a mammalian subject, the combination of metabolites comprising at least (a) one amino acid selected from glutamine, glutamate and serine, and one lipid, or (b) glutamine and glutamate, as a biomarker set for screening and/or diagnosing breast cancer. (a) one amino acid selected from glutamine, glutamate and serine, and one lipid, or (b) glutamine and glutamate,
A heating furnace for heating an annular component, comprising: a furnace body , wherein the furnace body encloses a sealed heating space, and the furnace body is equipped with a heat medium driving component and a support part for the annular component, and an interior of the furnace body further comprises: a guide part , comprising a top plate and an annular guide plate extending vertically downward from the circumference of the top plate , wherein the top plate and the annular guide plate together with respective inner walls of the furnace body form heat medium channels, the top plate has a backflow through hole at a position opposite to the heat medium driving component, the annular guide plate is mounted on the periphery of the annular component and has a number of first heat medium channels which are extended radially, each of which faces exactly to an outer circumferential surface of the annular component. a hollow cylinder , which is arranged in the annular component, and a circumferential space is preset between the hollow cylinder and the annular component, an upper end surface of the hollow cylinder is of a sealed structure, a lower edge of an inner circumferential surface of the annular component and an outer circumferential wall of the hollow cylinder form a sealed structure, characterised in that an inner chamber of the hollow cylinder communicates with the heat medium channels formed by the annular guide plate and a bottom wall of the furnace body , the hollow cylinder has second heat medium channels which are extended radially, and each of the second heat medium channels is opposite to the inner circumferential surface of the annular component. a guide part , comprising a top plate and an annular guide plate extending vertically downward from the circumference of the top plate , wherein the top plate and the annular guide plate together with respective inner walls of the furnace body form heat medium channels, the top plate has a backflow through hole at a position opposite to the heat medium driving component, the annular guide plate is mounted on the periphery of the annular component and has a number of first heat medium channels which are extended radially, each of which faces exactly to an outer circumferential surface of the annular component. a hollow cylinder , which is arranged in the annular component, and a circumferential space is preset between the hollow cylinder and the annular component, an upper end surface of the hollow cylinder is of a sealed structure, a lower edge of an inner circumferential surface of the annular component and an outer circumferential wall of the hollow cylinder form a sealed structure, characterised in that an inner chamber of the hollow cylinder communicates with the heat medium channels formed by the annular guide plate and a bottom wall of the furnace body , the hollow cylinder has second heat medium channels which are extended radially, and each of the second heat medium channels is opposite to the inner circumferential surface of the annular component.
An in-vehicle charge and discharge system, wherein the system comprises: an alternating current interface , an isolating transfer switch , a first converter , a second converter , a high-voltage battery interface , a low-voltage battery interface , and a controller , wherein the controller is configured to: control the isolating transfer switch to switch to a first conducting state, so that the alternating current interface is conducted with the high-voltage battery interface by using the first converter and the second converter that are connected in series; and control the first converter to work in a power factor correction mode or an inverting mode, and control the second converter to work in a direct current direct current isolating conversion mode; and the controller is further configured to: control the isolating transfer switch to switch to a second conducting state, so that the low-voltage battery interface is conducted with the high-voltage battery interface by using the first converter and the second converter that are connected in series; and control the first converter to work in a direct current direct current conversion mode, and control the second converter to work in the direct current direct current isolating conversion mode. the controller is configured to: control the isolating transfer switch to switch to a first conducting state, so that the alternating current interface is conducted with the high-voltage battery interface by using the first converter and the second converter that are connected in series; and control the first converter to work in a power factor correction mode or an inverting mode, and control the second converter to work in a direct current direct current isolating conversion mode; and the controller is further configured to: control the isolating transfer switch to switch to a second conducting state, so that the low-voltage battery interface is conducted with the high-voltage battery interface by using the first converter and the second converter that are connected in series; and control the first converter to work in a direct current direct current conversion mode, and control the second converter to work in the direct current direct current isolating conversion mode.
An oxygen-absorbing resin composition containing an ethylene terephthalate type polyester resin and an organic oxygen absorber and, further, containing cobalt in an amount, in the composition, of 10 to 30 ppm and titanium in an amount, in the composition, of 1 to 15 ppm calculated as elements; wherein the amount of any cobalt and the amount of any titanium contained in the polyester resin component of the composition is determined by a method in which: (a) a sample of the polyester resin is crushed into a powder by using a freeze-crushing machine; (b) the powder is weighed to be 0.5 g and introduced into a sealed container equipped with a Teflon-coated stainless steel jacket; (c) 6 ml of sulfuric acid and 3 ml of nitric acid are added thereto; (d) the container is sealed; (e) by using an electric furnace, the container is heated at 220°C for 20 hours, and the powder is completely decomposed; (f) yttrium is added thereto as an internal standard substance; (g) the mixture thereof is put into a graduated cylinder, to which ultra-pure water is added up to a graduate of 20 ml to obtain a solution for measurement; and (h) the solution is then measured by using an ICP emission analyzer manufactured by Thermo Fisher Scientific Inc.
A handle for an electrically operated personal care implement , the personal care implement being an oral care implement, the handle comprising a housing defining an inner cavity , the inner cavity accommodating at least a power source and a motor comprising an eccentric weight for operating the personal care implement , the motor being mounted on a swivel-mounted carrier , and the housing having a longitudinal extension and a substantially circular cross-sectional area extending substantially perpendicular to the longitudinal extension , wherein the substantially circular cross-sectional area has a diameter from about 12 mm to about 20 mm, preferably from about 13 mm to about 17 mm, more preferably about 15 mm, and and the housing is a metal tube housing .
A sealing glass paste, comprising a light absorbing material, wherein, the sealing glass paste further comprises glass powders, a ceramic filler, a resin and a solvent; the light absorbing material is selected from at least one of silicon carbide, copper chrome black and iron manganese black; characterized in that the weight percentage contents of the glass powders, the ceramic filler, the light absorbing material, the resin and the solvent are: glass powders: 20%-50%; ceramic filler: 5%-25%; light absorbing material: 3%-5%; resin: 10%-25%; and solvent: 20%-40%. glass powders: 20%-50%; ceramic filler: 5%-25%; light absorbing material: 3%-5%; resin: 10%-25%; and solvent: 20%-40%.
A magnetic clamp , for use in clamping a sideform in precast concrete manufacture, the clamp including: a housing ; a sideform connector for connecting the housing to the sideform; a magnet displaceably arranged within the housing ; a displacement mechanism displaceably arranged on the housing to displace the magnet relative to the housing ; and a force amplification mechanism connected to the magnet , at least a portion of the force amplification mechanism being interposed between the displacement mechanism and the magnet , characterised in that : the displacement mechanism includes a handle operable to pivot the magnet between a first, disengaged position, and a second, operative position in which the magnet is substantially fully in contact with a magnetic bed on which the clamp is mounted for use so as to clamp the sideform relative to the magnetic bed. a housing ; a sideform connector for connecting the housing to the sideform; a magnet displaceably arranged within the housing ; a displacement mechanism displaceably arranged on the housing to displace the magnet relative to the housing ; and a force amplification mechanism connected to the magnet , at least a portion of the force amplification mechanism being interposed between the displacement mechanism and the magnet , characterised in that : the displacement mechanism includes a handle operable to pivot the magnet between a first, disengaged position, and a second, operative position in which the magnet is substantially fully in contact with a magnetic bed on which the clamp is mounted for use so as to clamp the sideform relative to the magnetic bed.
A bacterial strain deposited at the Colección Española de Cultivos Tipo (CECT) by Servicio Galego de Saúde (SERGAS), on July 20, 2016, with accession number CECT 9174.
A method for adjusting a clutch characteristic curve, characterized by comprising steps of: obtaining a torque-stroke learning value for adjusting the clutch characteristic curve (S100); calculating a convergence value for each control point of the clutch characteristic curve, wherein the point at which the control point should move according to the learned value to be obtained is referred to as a convergence value ; calculating a difference value between the convergence value and a characteristic curve value for each control point (S120); and determining a new characteristic curve value of each control point according to whether a maximum value of the calculated difference values exceeds a preset reference value (S140), wherein the step of determining the new characteristic curve for each control point comprises a step of calculating the new characteristic curve value for each control point based on a preset step size when the maximum value of the calculated difference values exceeds the preset reference value, characterized in that : the step of calculating the new characteristic curve value for each control point comprises a step of calculating a new characteristic curve value based on a value obtained by multiplying the step size by a ratio of the change value of the corresponding control point to the change value of the control point at which the difference value is the maximum value, for each control point, wherein the change value means a value obtained by subtracting the characteristic curve value from the convergence value. obtaining a torque-stroke learning value for adjusting the clutch characteristic curve (S100); calculating a convergence value for each control point of the clutch characteristic curve, wherein the point at which the control point should move according to the learned value to be obtained is referred to as a convergence value ; calculating a difference value between the convergence value and a characteristic curve value for each control point (S120); and determining a new characteristic curve value of each control point according to whether a maximum value of the calculated difference values exceeds a preset reference value (S140), wherein the step of determining the new characteristic curve for each control point comprises a step of calculating the new characteristic curve value for each control point based on a preset step size when the maximum value of the calculated difference values exceeds the preset reference value, characterized in that : the step of calculating the new characteristic curve value for each control point comprises a step of calculating a new characteristic curve value based on a value obtained by multiplying the step size by a ratio of the change value of the corresponding control point to the change value of the control point at which the difference value is the maximum value, for each control point, wherein the change value means a value obtained by subtracting the characteristic curve value from the convergence value.
A surgical instrument, comprising: (a) an instrument body ; (b) an ultrasonic transducer assembly rotatably mounted along a longitudinal axis within the instrument body such that the ultrasonic transducer assembly is configured to rotate about the longitudinal axis, wherein the ultrasonic transducer assembly defines a first outer profile about the longitudinal axis in a plane that is transverse to the longitudinal axis; (c) a power cord projecting from the instrument body and configured to provide electrical power to the ultrasonic transducer assembly for operating an acoustic waveguide; and (d) a transducer slip joint positioned between the power cord and the ultrasonic transducer assembly and defining a second outer profile about the longitudinal axis in a plane that is transverse to the longitudinal axis, wherein the transducer slip joint is configured to electrically connect the power cord to the ultrasonic transducer assembly and mechanically connect the power cord to the ultrasonic transducer assembly such that the ultrasonic transducer assembly is configured to rotate relative to the power cord for inhibiting the power cord from winding upon rotation of the ultrasonic transducer assembly relative to the instrument body, wherein the second outer profile fits within the first outer profile of the ultrasonic transducer assembly. (a) an instrument body ; (b) an ultrasonic transducer assembly rotatably mounted along a longitudinal axis within the instrument body such that the ultrasonic transducer assembly is configured to rotate about the longitudinal axis, wherein the ultrasonic transducer assembly defines a first outer profile about the longitudinal axis in a plane that is transverse to the longitudinal axis; (c) a power cord projecting from the instrument body and configured to provide electrical power to the ultrasonic transducer assembly for operating an acoustic waveguide; and (d) a transducer slip joint positioned between the power cord and the ultrasonic transducer assembly and defining a second outer profile about the longitudinal axis in a plane that is transverse to the longitudinal axis, wherein the transducer slip joint is configured to electrically connect the power cord to the ultrasonic transducer assembly and mechanically connect the power cord to the ultrasonic transducer assembly such that the ultrasonic transducer assembly is configured to rotate relative to the power cord for inhibiting the power cord from winding upon rotation of the ultrasonic transducer assembly relative to the instrument body, wherein the second outer profile fits within the first outer profile of the ultrasonic transducer assembly.
A medicament delivery system, comprising: a medicament container ; and a plunger displaceably disposed relative to the medicament container for ejecting medicament from the medicament container; a delay mechanism ; wherein the delay mechanism is adapted to, subsequent to completion of medicament delivery, automatically activate a subsystem or initiate an operation, characterized in that a predetermined displacement of the plunger activates the delay mechanism prior to completion of medicament delivery from the medicament container, wherein the delay mechanism comprises: a delay activator and a rotatable spool; spool ; wherein the plunger includes a tail portion wrapped around the rotatable spool; wherein as the plunger advances in the medicament container, the tail portion unwinds from the spool; and wherein a predetermined rotation of the spool activates the delay activator, which in turn activates the delay mechanism. a medicament container ; and a plunger displaceably disposed relative to the medicament container for ejecting medicament from the medicament container; a delay mechanism ; wherein the delay mechanism is adapted to, subsequent to completion of medicament delivery, automatically activate a subsystem or initiate an operation, characterized in that a predetermined displacement of the plunger activates the delay mechanism prior to completion of medicament delivery from the medicament container, wherein the delay mechanism comprises: a delay activator and a rotatable spool; spool ; wherein the plunger includes a tail portion wrapped around the rotatable spool; wherein as the plunger advances in the medicament container, the tail portion unwinds from the spool; and wherein a predetermined rotation of the spool activates the delay activator, which in turn activates the delay mechanism. a delay activator and a rotatable spool; spool ; wherein the plunger includes a tail portion wrapped around the rotatable spool; wherein as the plunger advances in the medicament container, the tail portion unwinds from the spool; and wherein a predetermined rotation of the spool activates the delay activator, which in turn activates the delay mechanism.
A microporous membrane comprising a copolymerized high density polyethylene and a high density polyethylene, wherein the content of an α-olefin unit having 3 or more carbon atoms in the microporous membrane is 0.01 mol% or more and 0.6 mol% or less, and the viscosity average molecular weight of the microporous membrane, determined as described in the description, is less than 300,000.
A volumetric pump comprising a clamping device and a pump casing to which a flap or door for closing an accommodating chamber for a flexible tube is articulated, in which accommodating chamber a tube clamp is arranged that is configured to release the tube inserted therein while the flap or door is closed and to pinch off the tube in a sealing manner when the flap or door is opened, characterized in that the tube clamp includes a clamping blade being movably supported on the pump casing and being spring-pretensioned in the pinching direction, wherein the clamping blade at one portion forms a clamping surface (5.2) interacting with a clamping jaw (3.1) fixed to the pump casing and at another portion forms an engaging surface (5.3) of which a projection (4.1) provided on the flap or door slips off during a closing operation by a pivoting movement of the flap or door so that accordingly a force of movement is applied to the clamping blade against the spring pretension. a pump casing to which a flap or door for closing an accommodating chamber for a flexible tube is articulated, in which accommodating chamber a tube clamp is arranged that is configured to release the tube inserted therein while the flap or door is closed and to pinch off the tube in a sealing manner when the flap or door is opened, characterized in that the tube clamp includes a clamping blade being movably supported on the pump casing and being spring-pretensioned in the pinching direction, wherein the clamping blade at one portion forms a clamping surface (5.2) interacting with a clamping jaw (3.1) fixed to the pump casing and at another portion forms an engaging surface (5.3) of which a projection (4.1) provided on the flap or door slips off during a closing operation by a pivoting movement of the flap or door so that accordingly a force of movement is applied to the clamping blade against the spring pretension.
A method for analyzing a cell, comprising: (a) labeling said cell with a cell nucleic acid barcode sequence to generate a labeled cell, wherein a cell nucleic acid barcode molecule comprises said cell nucleic acid barcode sequence and a lipophilic moiety; (b) generating a partition comprising said labeled cell and a plurality of partition nucleic acid barcode molecules, wherein each partition nucleic acid barcode molecule of said plurality of partition nucleic acid barcode molecules comprises a partition nucleic acid barcode sequence; (c) permeabilizing or lysing said cell to provide access to a plurality of nucleic acid molecules therein; (d) generating (i) a barcoded nucleic acid molecule comprising said cell nucleic acid barcode sequence, or a complement thereof, and said partition nucleic acid barcode sequence, or a complement thereof, and (ii) a plurality of barcoded nucleic acid products each comprising a sequence of a nucleic acid molecule of said plurality of nucleic acid molecules and said partition nucleic acid barcode sequence, or a complement thereof; and (e) identifying said plurality of nucleic acid molecules as originating from said cell. (a) labeling said cell with a cell nucleic acid barcode sequence to generate a labeled cell, wherein a cell nucleic acid barcode molecule comprises said cell nucleic acid barcode sequence and a lipophilic moiety; (b) generating a partition comprising said labeled cell and a plurality of partition nucleic acid barcode molecules, wherein each partition nucleic acid barcode molecule of said plurality of partition nucleic acid barcode molecules comprises a partition nucleic acid barcode sequence; (c) permeabilizing or lysing said cell to provide access to a plurality of nucleic acid molecules therein; (d) generating (i) a barcoded nucleic acid molecule comprising said cell nucleic acid barcode sequence, or a complement thereof, and said partition nucleic acid barcode sequence, or a complement thereof, and (ii) a plurality of barcoded nucleic acid products each comprising a sequence of a nucleic acid molecule of said plurality of nucleic acid molecules and said partition nucleic acid barcode sequence, or a complement thereof; and (e) identifying said plurality of nucleic acid molecules as originating from said cell.